Silodosin as a medical expulsive therapy for distal ureteral stones: A systematic review and meta-analysis
Authors:
Open Access
- 29 December 2022
- journal article
- review article
- Published by Wolters Kluwer Health in Indian Journal of Urology
- Vol. 39 (1) , 21-26
Abstract
Introduction: Tamsulosin is the most commonly used medical expulsive therapy (MET). However, it does not alleviate ureteral colic. It is important to develop MET that can reduce ureteral colic while maintaining a high stone clearance rate. Silodosin is an α1A adrenoceptor with high affinity and selectivity for the distal ureter, which may reduce ureteral colic and enable stone expulsion for distal ureteral stones. Therefore, we performed this systematic review and meta-analysis to evaluate the efficacy of silodosin as MET and its role in reducing ureteral colic among patients with distal ureteral stones. Materials and Methods: This research was conducted in accordance with the Cochrane Handbook for Systematic Review and Intervention, in adherence with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses, and was registered in the International Prospective Register of Systematic Reviews (PROSPERO CRD42021249003). A comprehensive literature search was performed in several databases including Medline, EMBASE, and Scopus up to July 2021 for randomized trials comparing silodosin with placebo for MET. RevMan 5.4 was used for data analysis. Results: A total of six randomized controlled trials were included in this analysis with a total of 907 patients. Our analysis revealed that the patients who received silodosin had significantly higher stone expulsion rate (SER) (odds ratio [OR] 3.33, 95% confidence interval [CI] 2.34, 4.76, P < 0.01), significantly shorter stone expulsion time (SET) (mean difference −3.79, 95% CI −4.51, −3.06, P < 0.01), and lower analgesic use (OR 0.4, 95% CI 0.23, 0.69, P < 0.01) compared to the group receiving placebo. Conclusion: Silodosin showed significantly higher SER, lower SET and lower analgesic use in patients with distal ureteral stones as compared to a placebo.Keywords
This publication has 19 references indexed in Scilit:
- Efficacy of Silodosin in Expulsive Therapy for Distal Ureteral Stones: A Randomized Double-blinded Controlled Trial.2016
- Efficacy of silodosin in the treatment of distal ureteral stones 4 to 10 mm in diameter.2015
- Silodosin to Facilitate Passage of Ureteral Stones: A Multi-institutional, Randomized, Double-blinded, Placebo-controlled TrialEuropean Urology, 2015
- Administration of the selective alpha 1A-adrenoceptor antagonist silodosin facilitates expulsion of size 5–10 mm distal ureteral stones, as compared to controlInternational Urology and Nephrology, 2013
- Efficacy of selective α1A adrenoceptor antagonist silodosin in the medical expulsive therapy for ureteral stonesInternational Journal of Urology, 2011
- Characterization of α1-adrenoceptor Subtypes Mediating Contraction in Human Isolated UretersUrology, 2011
- Silodosin in the treatment of benign prostatic hyperplasiaDrug Design, Development and Therapy, 2010
- Effects of silodosin and tamsulosin on the urethra and cardiovascular system in young and old dogs with benign prostatic hyperplasiaEuropean Journal of Pharmacology, 2009
- Examination of alpha 1 adrenoceptor subtypes in the human ureterInternational Journal of Urology, 2007
- Medical therapy to facilitate urinary stone passage: a meta-analysisThe Lancet, 2006